Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Dasta

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Critical Care Medicine|May 1, 1992
Evolving role of the pharmacist in critical careJ F Dasta, D M Angaran
Clinical Pharmacy|March 1, 1987
More on variability in aminoglycoside volume of distributionJ F Dasta, D K Armstrong
Pharmacotherapy|January 1, 1991
Clinical significance of the benzodiazepine-theophylline interactionM F Bonfiglio, J F Dasta
Critical Care Medicine|April 1, 1988
Variability in aminoglycoside pharmacokinetics in critically ill surgical patientsJ F Dasta, D K Armstrong
Critical Care Medicine|May 1, 1994
Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literatureS M Watling, J F Dasta
Pharmacotherapy|November 1, 1994
Defining and achieving optimum therapeutic goals in critically ill patientsJ F Dasta, C C Brackett
The Annals of Pharmacotherapy|October 30, 1998
Comment: once-daily aminoglycoside dosing in critically ill patientsT A Wolfe, J F Dasta
American Pharmacy|February 1, 1982
Topical nitroglycerin: a new twist to an old standbyJ F Dasta, D R Geraets
The Annals of Pharmacotherapy|January 1, 1995
Use of nitric oxide synthase inhibitors as a novel treatment for septic shockT A Wolfe, J F Dasta
The Annals of Pharmacotherapy|March 1, 1993
Aminoglycoside dosing considerations in intensive care unit patientsS M Watling, J F Dasta
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Critical Care Medicine|May 1, 1992
Evolving role of the pharmacist in critical careJ F Dasta, D M Angaran
Clinical Pharmacy|March 1, 1987
More on variability in aminoglycoside volume of distributionJ F Dasta, D K Armstrong
Pharmacotherapy|January 1, 1991
Clinical significance of the benzodiazepine-theophylline interactionM F Bonfiglio, J F Dasta
Critical Care Medicine|April 1, 1988
Variability in aminoglycoside pharmacokinetics in critically ill surgical patientsJ F Dasta, D K Armstrong
Critical Care Medicine|May 1, 1994
Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of the literatureS M Watling, J F Dasta
Pharmacotherapy|November 1, 1994
Defining and achieving optimum therapeutic goals in critically ill patientsJ F Dasta, C C Brackett
The Annals of Pharmacotherapy|October 30, 1998
Comment: once-daily aminoglycoside dosing in critically ill patientsT A Wolfe, J F Dasta
American Pharmacy|February 1, 1982
Topical nitroglycerin: a new twist to an old standbyJ F Dasta, D R Geraets
The Annals of Pharmacotherapy|January 1, 1995
Use of nitric oxide synthase inhibitors as a novel treatment for septic shockT A Wolfe, J F Dasta
The Annals of Pharmacotherapy|March 1, 1993
Aminoglycoside dosing considerations in intensive care unit patientsS M Watling, J F Dasta
Pageof 7